Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression
PLOS Biology · 02.05.2023 · 21 (5) · e3002088
DOI: 10.1371/journal.pbio.3002088 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Biology, online erschienen am 02.05.2023. Verfasst von Baohong Wu und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, …. Hauptthemen laut MEDLINE: Single-Cell Gene Expression Analysis, Leukemia, Myeloid, Acute. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Sichuan Science and Technology Program, the 1.3.5. Project for Disciplines of Excellence.
Abstract (Originalsprache)
Leukemogenesis is proposed to be a multistep process by which normal hematopoietic stem and progenitor cells are transformed into full-blown leukemic cells, the details of which are not fully understood. Here, we performed serial single-cell transcriptome analyses of preleukemic and leukemic cells (PLCs) and constructed the cellular and molecular transformation trajectory in a Myc -driven acute myeloid leukemia (AML) model in mice, which represented the transformation course in patients. We found that the Myc targets were gradually up-regulated along the trajectory. Among them were splicing factors, which showed stage-specific prognosis for AML patients. Furthermore, we dissected the detailed gene network of a tipping point for hematopoietic stem and progenitor cells (HSPCs) to generate initiating PLCs, which was characterized by dramatically increased splicing factors and unusual RNA velocity. In the late stage, PLCs acquired explosive heterogeneity through RNA alternative splicing. Among them, the Hsp90aa1 hi subpopulation was conserved in both human and mouse AML and associated with poor prognosis. Exon 4 skipping of Tmem134 was identified in these cells. While the exon skipping product Tmem134β promoted the cell cycle, full-length Tmem134α delayed tumorigenesis. Our study emphasized the critical roles of RNA splicing in the full process of leukemogenesis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Hematology and Institute of Hematology, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
- State Key Laboratory of Biotherapy, Sichuan University, Chengdu, Sichuan, China.
- Key Laboratory of Birth Defects and Related Diseases of Women and Children, West China Second University Hospital, State Key Laboratory of Biotherapy, Sichuan University, Chengdu, China.
ORCID-Profile: Chong Chen
Förderung
- National Natural Science Foundation of China
- Sichuan Science and Technology Program
- the 1.3.5. Project for Disciplines of Excellence
- Sichuan University Postdoctoral Interdisciplinary Innovation Fund
Zitieren
APA
Wu, B., Chen, X., Pan, X., Deng, X., Li, S., Wang, Z., Wang, J., Liao, D., Xu, J., Chen, M., Zhao, C., Xue, Z., Wang, Y., Niu, T., Lin, J., Chen, L., Liu, Y., & Chen, C. (2023). Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression. PLOS Biology, 21(5), e3002088. https://doi.org/10.1371/journal.pbio.3002088
Vancouver
Wu B, Chen X, Pan X, Deng X, Li S, Wang Z, et al. Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression. PLOS Biology. 2023;21(5):e3002088. doi:10.1371/journal.pbio.3002088
BibTeX
@article{Wu2023,
author = {Wu, Baohong and Chen, Xuelan and Pan, Xiangyu and Deng, Xintong and Li, Shujun and Wang, Zhongwang and Wang, Jian and Liao, Dan and Xu, Jing and Chen, Mei and Zhao, Chengjian and Xue, Zhihong and Wang, Yuan and Niu, Ting and Lin, Jingwen and Chen, Lu and Liu, Yu and Chen, Chong},
title = {Single-cell transcriptome analyses reveal critical roles of RNA splicing during leukemia progression},
journal = {PLOS Biology},
year = {2023},
volume = {21},
number = {5},
pages = {e3002088},
doi = {10.1371/journal.pbio.3002088}
}
EUVIMED